$163M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | GLUE Monte Rosa Therapeutics Inc | 3.2M | +0.0% | $77M | 47.3% |
| 2 | IPSC Century Therapeutics Inc | 12.2M | +0.0% | $30M | 18.3% |
| 3 | JBIO Jade Biosciences Inc | 991,783 | −35.0% | $22M | 13.6% |
| 4 | LENZ Lenz Therapeutics Inc | 2.7M | +0.0% | $15M | 9.3% |
| 5 | CTNM Contineum Therapeutics Inc | 542,628 | +0.0% | $9M | 5.5% |
| 6 | CRSP Crispr Therapeutics Ag | 148,831 | +0.0% | $8M | 5.0% |
| 7 | SKYE Skye Bioscience Inc | 2.0M | +0.0% | $1M | 0.9% |
| 8 | TPST Tempest Therapeutics, Inc. | 269,772 | +0.0% | $299,447 | 0.2% |